Sharechat Logo

ANZ predicts profit drop on credit charges

Friday 6th March 2009

Text too small?
ANZ National Bank, New Zealand's largest lender, said profit will fall this year as the prolonged recession squeezes borrowers and boosts credit provisions.

The unit of Melbourne-based Australia & New Zealand Banking Group posted a 32% drop in profit to $210 million for the three months ended Dec. 31, according to a statement today. It took a credit impairment charge of $94 million, up from $32 million a year earlier, and said full-year provisions may double to $572 million.

"Volume growth has been flat and margins under pressure due to higher wholesale funding costs, competition for deposits and break costs on mortgages as customers take advantage of lower interest rates," the company said.

"The New Zealand economy contracted sharply with delinquencies subsequently rising strongly off a historically low base," it said. Provisions "could approach double those of last year," when they were $286 million.

Since the end of the quarter, the bank has taken a $161 million charge against revenue for its 49% share of costs associated with the payment offer to investors in two ING New Zealand frozen funds.

Net interest income in the latest quarter rose 5% to $601 million. The bank said it is well capitalized, with tier one capital of 8.19% and total capital of 11.68%.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors